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CASE REPORT
A 47-year-old womanwith no significant medical history presented to an outside hospital with a 3-week history of intermittent
nausea, vomiting, abdominal pain, and one episode of hematemesis. Laboratory evaluation was unrevealing. Upper endoscopy
revealed a 12-mm umbilicated subepithelial lesion with a reddish depression located at the incisura (Figure 1). Superficial
biopsies demonstrated mild chronic gastritis. Computed tomography of the abdomen and pelvis revealed no suspicious
lesions. Her symptoms resolved shortly after her outside hospital admission and were believed to be due to a viral gastro-
enteritis. She was referred to our institution for endoscopic ultrasound (EUS) and possible resection. EUS revealed a 12-mm
hypoechoic subepithelial lesion originating from the deep mucosa (layer 2) (Figure 2). Endoscopic submucosal dissection was
considered, although endoscopic mucosal resection (EMR) was believed to be adequate because the lesion was small enough to
fit into a cap. Band EMR was performed with complete resection of the lesion. Histology revealed bland spindle cells in
a myxoid stroma arranged in small fascicles with a whorling appearance (Figure 3). Immunohistochemical (IHC) staining
revealed that the tumor cells were positive for GLUT-1 but were negative for desmin, CD117 (c-KIT), CD34, epithelial
membrane antigen, and S-100 consistent with gastric perineurioma. Interval upper endoscopy and EUS were performed at 4
months without evidence of residual or recurrent lesion.
Gastric perineuriomas are exceedingly rare and should be distinguished from other spindle cell/mesenchymal lesions. The
differential diagnosis for a perineurioma includes gastrointestinal stromal tumors (GISTs), inflammatory fibroid polyps,
Schwann cell hamartomas, fibromatosis, and inflammatory myofibroblastic tumors.1 IHC testing can help differentiate these
Figure 1. Esophagogastroduodenoscopy demonstrated a 12-mm
umbilicated subepithelial lesion at the incisura.
Figure 2. Endoscopic ultrasound demonstrated a 12-mm hypo-
echoic lesion in the deep mucosa (layer 2).
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lesions because GIST typically stain positive for CD117, CD34, and
DOG1, whereas neuronal lesions express S100 which is negative in
perineuriomas.2 GLUT-1 has been demonstrated to be a reliable
IHC marker for perineurial cells.3 It is important to differentiate
agastricperineurioma fromthemorecommonGISTbecausegastric
perineuriomas are benign, whereas GIST can be more aggressive.
To our knowledge, this is the fifth reported case of gastric
perineurioma and second reported case in the United States.
Furthermore, these benign lesions can be managed endoscop-
ically with EMR. Given the rarity of this lesion, there are cur-
rently no standard recommendations for follow-up endoscopy.
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Figure 3. Histology demonstrated bland spindle cells in a myxoid stroma with a whorling appearance.
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